Wall Street Reassessment: Analyst Opinion Evolution on CC. UBS, Morgan Stanley, and J.P. Morgan cut Chemours price targets by as much as 37.9% after a 2026 guidance cut that the lawsuit alleges followed months of overstated Opteon aftermarket demand.
Read more at prnewswire.comCC Shareholder Alert: December 7, 2026 Lead Plaintiff Deadline in The Chemours Company Securities Class Action - Contact Levi & Korsinsky
Barchart·10/14/2026 09:18:00
語音播報
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.